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Respiratory illnesses are a leading cause of death for children worldwide, with the
majority of these cases occurring from preterm birth complications or acute respiratory
infections. Appropriate respiratory intervention must be provided quickly to lower the
chances of death or permanent harm. As a result, respiratory support given in prehospital
and interfacility transport can substantially improve health outcomes for these patients,
particularly in areas where transportation time to appropriate facilities is lengthy. Existing
literature supports the use of non-invasive ventilation (NIV), such as nasal or bilevel
continuous positive airway pressure, as a safe form of respiratory support for children
under 18 years old in certain transportation settings. This mini review summarizes
the literature on pediatric NIV in transport and highlights significant gaps that future
researchers should address. In particular, we identify the need to: solidify clinical
guidelines for the selection of eligible pediatric patients for transport on NIV; explore the
range of factors influencing successful NIV implementation during transportation; and
apply appropriate best practices in low and middle income countries.
Keywords: non-invasive ventilation, respiratory intervention, emergency transportation, oxygen therapy, pediatric,
neonatal, low resource
INTRODUCTION
The response to the COVID-19 pandemic has increased efforts to expand oxygen availability
worldwide. This wider availability has positive implications for pediatric clinical care beyond
the pandemic (1). While children typically experience only minor symptoms from COVID-19,
∼700,000 children globally under the age of five die each year due to lower respiratory infections
such as bacterial and viral pneumonias (2, 3). Additionally, over 10% of newborns globally are
born prematurely (4). Many of these newborns require respiratory support, as just minutes without
adequate oxygen or ventilatory support can lead to permanent brain and lung injuries or death
(5, 6). Improved oxygen availability alongside increased accessibility to treatments such as non-
invasive ventilation (NIV) will be pivotal to decrease childhood mortality and morbidity from
respiratory causes. Different forms of NIV, such as continuous positive airway pressure (CPAP),
bilevel positive airway pressure (BiPAP), and nasal high flow therapy (nHFT), have been shown
to safely and effectively provide respiratory support for children in respiratory distress in health
facilities (7). When compared to invasive ventilation, NIV is simpler to apply, more cost-effective,
and has less risks associated with it (8, 9).
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In many regions of the world and particularly in low and
middle income countries (LMICs), the transport time to a
facility equipped to care for premature newborns or infants in
respiratory distress may be hours long (10, 11). However, data
on the use of NIV for children in transportation settings are
minimal, and even more limited in LMIC contexts. As COVID-
19 exacerbates existing healthcare inequities and leads to more
children falling ill and mothers giving birth at home, it is
more crucial than ever to increase research and attention on
the use of NIV for children during prehospital and interfacility
transport (12–14).
A systematic review published in 2018 synthesized eight
studies on the use of NIV during pediatric critical care transport
(15). The authors found that minor adverse events occurred in 1-
4% of transfers, leading them to suggest that NIV in transport
is safe in the settings studied (15). This review synthesizes
additional literature on NIV during transportation and describes
not only the safety considerations, but also the importance of
standardized patient selection protocols and other factors that
influence successful implementation. By analyzing new research
and highlighting the current gaps in knowledge, this review
provides actionable research questions for further investigation.
METHODS
The search query in Figure 1 was informed by the 2018
systematic review and used across the same databases (PubMed,
EMBASE, Cochrane Central Register for Controlled Trials,
African Index Medicus, and Web of Science) from the date
of their search (March 15, 2017) through February 1st, 2021
(15). Additionally, Harvard Hollis library and Google Scholar
were used to forward search any additional relevant references.
Articles included in this study were limited to those with full
text availability in English, and discussed the use of NIV in
prehospital and transportation settings for children under 18
years old. Articles were excluded if they were not original
research or if they were unrelated to NIV in a prehospital or
transportation setting.
RESULTS
This mini review includes 15 papers that are cataloged in
Table 1. Eight of these studies were included in Cheema et al.’s
systematic review, five are additional observational studies, one
is an epidemiological study of NIV use, and one is a qualitative
survey. While the earliest article was published in 2005, the
past decade has seen a steady increase in studies published on
the topic.
Safety
Cheema et al.’s systematic review of eight studies suggested that
NIV is safe to use in transport for children under age 18 (15).
Three of 858 patients (0.4%) required escalation of the mode
of ventilation during transport (15). Five additional studies in
our review demonstrated the safety of NIV in lengthy ground
and air transport, in rural settings, and for preterm neonates
outside the hospital setting (16, 20, 23, 26, 29). In one study,
none of 118 pediatric patients on NIV during transport required
intubation, despite a mean transport time of 163min (20). Two
studies conducted in remote settings suggested that nCPAP and
nHFT are safe in air transport (23, 26). Another study reported no
adverse events in the interfacility transfer of 99 preterm neonates
on nCPAP and concluded that this practice was both safe and
cost-effective (29).
Use of NIV in transportation settings decreases the need for
invasive ventilation and consequently avoids the risks associated
with this practice (8, 9, 16, 27). Invasive ventilation requires
monitoring and sedation and increases the risk of potential
lung damage from barotrauma (9). Additionally, patients with
comparable disease severity have longer hospital stays when
managed with invasive ventilation compared with NIV (9).
In contrast, NIV is simpler to apply and can be easily
discontinued when necessary (8). A study conducted in Australia
on interhospital transfer of children under 2 years old found
that prior to introduction of high flow nasal cannula (HFNC)
in transport, 49% of the children were transported on invasive
ventilation (27). After introduction of HFNC, this percentage
decreased to 33% (27). Additionally, none of the patients
transported on HFNC required intubation during transport (27).
These results were supported by other studies, which described
that although many patients did not require invasive ventilation,
most would have been intubated during transport due to a lack
of other treatment options (9, 25, 26). With the increasing use
of NIV in transport, more of these children can avoid invasive
ventilation (28).
While these studies suggest that NIV is safe to use during
transport for children in their respective settings, none were
conducted in LMICs. Further research should investigate the
safety of NIV in LMICs. Once safety has been demonstrated in
low-resource settings, a shift in focus toward implementation
research may help make widespread use more feasible.
Patient Selection
Many studies included in this review described the challenge
of determining the best method of ventilatory support for a
patient in transport and emphasized the need for evidence-
based clinical guidelines (9, 18–20, 22, 23, 25). This decision
requires weighing the risks of providing inadequate ventilation
using NIV vs. the risks of complications from invasive ventilation
(22). Beyond clear contraindications for NIV such as a
pneumothorax, cardiorespiratory arrest, and a complete upper
airway obstruction, there are few agreed upon indicators for the
selection of patients for NIV in transport (8, 17, 22). This review
suggests three parameters that could be included in a protocol
for selection of NIV-eligible patients: (1) a limited stabilization
period before transport, (2) a threshold for the required fraction
of inspired oxygen (FiO2), and (3) a threshold for the blood
hemoglobin oxygen saturation (SpO2)/FiO2 ratio (21–25).
The first parameter is the stabilization period, the length
of time during which a patient adjusts to a new treatment
and is monitored for treatment effectiveness before beginning
interfacility transport (9, 21, 22). One study found that patients
transported on nHFT who required an increase in flow rate
(≥2 L/min above the starting flow rate) and/or an increase
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FIGURE 1 | Search query.
TABLE 1 | Summary table of included studies.
References Country Type of NIV Transport
Setting
Age of Patients*
*as reported by study
Number of
participants
Abraham et al. (16) Australia nHFT Ground
Air
Median (IQR): 28 days
(13–51)
118
Baird et al. (17) United States BiPAP
CPAP
Ground Mean (SD): 6 yr (5)
Mean (SD): 0.8 yr (0.7)
25
Bomont and Cheema (18) United Kingdom nCPAP* Ground Mean (SD): 28.3 d (24.3) 100
Fleming et al. (9) Australia CPAP Ground Mean (SD): 54 d (39) 51
Hansen et al. (19) United States BVM† Ground N/A N/A
Holbird et al. (20) Canada HFNC‡
CPAP
BiPAP
Ground Mean (SD): 2.3 yr (3.6) 118
Jani et al. (21) Australia nCPAP Ground Preterm neonates—Median
GA (range): 30 wk (27–31)
44
Millan et al. (22) Spain CPAP Ground Median (IQR): 3.4 mo
(1.2–17)
108
Muniyappa et al. (23) United States nHFT Ground
Air
Median: <48 h 195
Murray and Stewart (24) United Kingdom nCPAP Ground
Air
Median (range): 1 d (0–175) 207
Resnick and Sokol (25) Australia CPAP Ground Median (range): 8 h (1–48) 166
Sheffield and Sheffield (26) Canada nCPAP Air Mean: 21 d 5
Schlapbach et al. (27) Australia HFNC Ground Mean (range): 6.5 mo
(0–24)
160
Trevisanuto et al. (28) Italy HFNC
CPAP
BiPAP
Ground Range: At birth to >30
days
3,337
Zein et al. (29) Canada nCPAP Ground Preterm neonates—Median




Bag valve mask manual resuscitation, ‡High flow nasal cannula.
in the FiO2 (≥0.20 above the starting FiO2) during transport
had statistically significant longer stabilization periods (56 ±
25min) than the patients who did not (39 ± 18min) (23). While
requiring increases in nHFT parameters does not signify a failure
of nHFT in transport, it may indicate that a patient’s condition
is deteriorating or not adequately treated by NIV (23). This
preliminary difference in the stabilization period suggests that
with additional evidence, the length of a stabilization period can
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be used to identify patients who may need a different method of
ventilation. Another study required significant improvement in a
patient’s severity score1 within 30min of treatment, otherwise the
method of ventilation was changed before beginning transport
(22). Using this requirement, the mean stabilization time for
patients transported on NIV was 48min (22). Jani et al. used
a more flexible method and observed patients for “∼30min or
until stabilization” to determine whether it was necessary to
escalate the method of ventilation (21). It appears that a limited
stabilization period may help identify if escalation of ventilation
is required prior to transport, but at present there is no consensus
on how long this stabilization time should be.
Multiple studies suggested using the required FiO2 to
determine the best method of ventilation for children (21, 23–
25). A study of 166 newborns transported on nCPAP compared
key measurements of disease severity between patients who
required intubation within 24 h of transport and those who did
not (25). FiO2 prior to transport was the only measurement
with a statistically significant difference between these two groups
(25). Patients who were intubated within 24 h of transport
required higher FiO2 prior to transport (median = 0.55) and
their oxygen requirement decreased only minimally after CPAP
was administered (median = 0.02) (25). In contrast, patients
transported on CPAP without requiring intubation required a
lower FiO2 (median = 0.45) and had a larger decrease in their
oxygen requirement (median= 0.13) (25). Similarly, Murray and
Stewart found that patients who were intubated within 24 h of
transport had a mean initial FiO2 of 0.5, while patients who were
not intubated had a mean initial FiO2 of 0.37 (24). Thus, Murray
and Stewart recommended intubating patients if they require
an FiO2 higher than 0.45 prior to transport and if this FiO2
requirement is not reduced within 20min of CPAP initiation
(24). However, there was no consensus across papers on what the
FiO2 threshold should be.
The third parameter, the SpO2/FiO2 (S/F) ratio, compares
the SpO2 and FiO2 measurements to determine the severity of
respiratory distress (30). Muniyappa et al. found that the S/F ratio
was significantly lower for patients who failed NIV in transport
compared to those who did not (23). In another study, in cases
where acute respiratory distress syndrome was suspected, an
S/F ratio <150 after 30min of NIV treatment was used as a
contraindication for the continuation of NIV in transport (22).
A study on the use of HFNC for children in the hospital setting
used a different S/F ratio threshold and recommended escalating
the mode of ventilation if an S/F ratio was <200 after 60min of
HFNC (30). Further research is needed to determine an optimal
S/F ratio threshold for the use of different NIV methods on
children in transportation settings.
These three parameters (stabilization period, FiO2 level, and
S/F ratio) could provide a starting point to guide patient selection
for NIV during transportation. While decisions may differ based
on diagnosis, patient ages, transport distances, and available
resources, development of evidence-based clinical pathways is an
important area for further work.
1Millan et al. used the Wood-Downes severity score for patients with asthma, and
the BROSJOD score for patients with bronchiolitis.
Implementation
In order to effectively use NIV during pediatric transport, it is
essential to consider factors that influence implementation. For
example, NIV devices integrated into medical transport settings
must be well-suited to the unique challenges presented by ground
or air transportation. It is particularly important to consider
durability, weight, size, and compatibility with various power
sources and other respiratory care equipment (8).
Multiple studies in this review emphasized the importance
of training and experience to successfully integrate NIV into
pediatric transport (17–20). A survey of prehospital providers
found that they had low confidence with pediatric respiratory
emergencies, particularly regarding patient assessment and
management (19). Anxiety with pediatric respiratory emergency
care increases the likelihood of medical errors, especially in
critically ill cases (19). Given the high level of skill and experience
required for use of NIV in transport, nine out of the 12
observational studies in this review described use of a specialized
transport team (9, 17, 18, 20–24, 27). These specialized transfer
units usually consist of a transport nurse and physician and/or
respiratory therapist with significant training and experience in
the field (18, 21, 23). In one study, paramedics in an interhospital
transport service underwent 200 h of training on adult and
pediatric transport medicine, which included 5 h of training on
NIV and 2 h on advanced pediatric airway skills (17). These
rigorous programs increased team members’ exposure to the
practice of pediatric NIV which gave the teams more confidence
in deciding which patients may benefit from NIV, applying NIV
to these patients, and managing most complications (19, 23).
While specialized transport teams may not be available in low-
resource health systems, additional training on pediatric NIV
may facilitate the use of NIV during transport in these settings.
NIV During Transportation in LMICs
While we did not find any research in LMICs on the use of NIV
in transportation settings, previous work on the effectiveness
of bCPAP in LMIC hospitals called for further investigation
into transportation and highlighted it as a key link to improve
respiratory care (31, 32); (Dada et al. under review). In
LMICs, additional factors such as long transport times, limited
availability of appropriate training, limited resources in health
facilities, and low population density must be considered in the
implementation of NIV (23, 26). While our literature search
did not identify any studies conducted in LMICs, two studies
conducted in rural settings in Canada and Utah cited barriers
similar to what may be expected in LMICs (23, 26). Despite
lengthy travel times, all treated infants arrived in stable condition
and no adverse events were recorded in these two studies
(23, 26). Although in both studies providers had access to air
transport and specialized transfer teams, the results suggest
that implementation of NIV in transport in LMICs may be
feasible. Additionally, Zein et al. showed that the use of nCPAP
to transfer patients from a level three hospital to a level two
neonatal intensive care unit (NICU) saved 2.65 million Canadian
dollars and freed up at least 848 days of NICU beds (29). This
suggests that using NIV in transport for children may have
financial benefits that could help maximize the use of limited
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resources in LMICs. Research in low resource settings is needed
to understand barriers and facilitators to quality NIV treatment
during transportation.
DISCUSSION
The observational studies included in this review primarily
focused on the safety of NIV for children in transportation
settings (15). These studies endorsed the use of NIV to provide
safe and adequate respiratory support and to avoid additional
risks associated with invasive ventilation (9, 17, 18, 20–27,
29). Future research should determine the requirements for
healthcare systems to safely introduce NIV into transportation
systems. Once this is established, other areas can be investigated,
such as comparing the efficacy of different modes of NIV in
transportation. To aid in this effort, a standard protocol must
be developed to identify patients eligible for successful NIV in
transport. While there is some consensus on the parameters to
include in a protocol, the included studies primarily focus on
term and preterm infants, and it is unclear if these parameters
are applicable to older children. Thus, further studies are
needed to better understand optimal stabilization periods and
FiO2 and S/F ratio thresholds, and to adapt these findings
to different age groups, diagnoses, and NIV methods (21–25).
Lastly, it is important to note that assessing these metrics requires
technology, such as pulse oximeters, that is not always available
in low-resource settings or in transportation vehicles. The process
for patient selection may need to include decision trees based on
limited available resources.
The current literature does not adequately address the
preconditions necessary to integrate NIV into the transportation
segment of a health system. For example, the need for NIV
devices compatible with transportation vehicles appears clear, but
the exact requirements for successful introduction of NIV into
new settings are not well-understood (8). Similarly, many studies
emphasized the necessity of a well-trained team, but very few
studies reported details on the training processes (17–20). More
research is needed to determine howmedical transport education
can be developed to support successful NIV.
Finally, the lack of NIV studies from LMICs impedes
understanding of the extent to which NIV is being used for
children in transportation in these settings, if at all, and the
degree to which NIV, if being used, is improving pediatric patient
outcomes. With 60% of LMIC populations residing more than
eight kilometers from healthcare facilities, long transport times
should be an additional consideration in the implementation of
NIV in LMICs (33). To date, studies conducted in rural settings
with mean transport distances up to 236 kilometers suggest
that this barrier can be overcome (20, 23, 26). However, in
many LMICs <1% of people have access to emergency medical
transportation services, resulting in patients relying on their
own means of transportation (33). When combined with limited
access to oxygen, it must be acknowledged that in some areas it
may not be possible to use NIV in transportation. It is essential
for new studies to investigate what is necessary for safe and
effective implementation of NIV in transportation in LMICs.
Overall, data on NIV for children in transportation are limited
by the ethical complications of working with these high-risk
populations. For example, researchers are unable to conduct
randomized controlled trials to determine the effectiveness of
NIV in various settings (15). As previous studies have stated, the
existing data are challenging to synthesize due to the variety in
methods, metrics, and patient populations (15, 23). We did not
conduct a systematic review or critical appraisals of the studies in
this review. We also note that limited sample sizes and practice
biases could affect the quality of the studies’ results.
CONCLUSION
NIV for newborns and children appears safe to use in high
resource transportation settings and can even improve patient
outcomes. More research is needed to develop protocols
for optimizing patient selection and to inform large-scale
implementation strategies. Implementation of NIV in pediatric
transport depends on resources and conditions within healthcare
systems. In high-resource settings, implementation efforts may
focus on refining current practices, such as utilization of
specialized transport teams. In LMICs there are additional
challenges to overcome, but little is currently known about the
barriers and facilitators to optimal use of NIV in transport in
these settings. Such information would enable efforts to integrate
NIV for children intomore prehospital and interfacility transport
settings around the world.
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